Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging role of S100B protein implication in Parkinson’s disease pathogenesis
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 4, pp. 1445-1453
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Pathophysiology of RAGE in inflammatory diseases
Hanbing Dong, Yue Zhang, Yu Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 112
The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker
Fabrizio Michetti, Maria Elisabetta Clementi, Rosa Di Liddo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9605-9605
Open Access | Times Cited: 50
Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics
Amrita Kulkarni, Preeti Kumari, Kamatham Pushpa Tryphena, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101816-101816
Closed Access | Times Cited: 39
The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases
Armando Rojas, Cristian Lindner, Iván Schneider, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 412-412
Open Access | Times Cited: 14
Blood-brain barrier biomarkers
Juan F. Zapata-Acevedo, Alejandra Mantilla-Galindo, Karina Vargas-Sánchez, et al.
Advances in clinical chemistry (2024), pp. 1-88
Closed Access | Times Cited: 9
Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease
Wen Li, Qiuping Chen, Cheng Peng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 403-403
Open Access | Times Cited: 1
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Geetika Nehra, Bryan Maloney, Rebecca Smith, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mag-Net: Rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome
Christine Wu, Kristine A. Tsantilas, Jea Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 21
Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
Nina Rostgaard, Markus Harboe Olsen, Maud Eline Ottenheijm, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells
Irene Tsilioni, Theoharis C. Theoharides
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6704-6714
Closed Access | Times Cited: 15
Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury
Tammam Abboud, Veit Rohde, Dorothée Mielke
BMC Neuroscience (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Vortioxetine Attenuates Rotenone-Induced Enteric Neuroinflammation via Modulation of the TLR2/S100B/RAGE Signaling Pathway in a Rat Model of Parkinson's Disease
Dilara Nemutlu Samur, Sendegül Yıldırım, Erkan Maytalman, et al.
Neuropharmacology (2025), pp. 110385-110385
Closed Access
Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders
Fabrizio Michetti, Gabriele Di Sante, Maria Elisabetta Clementi, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 446-458
Closed Access | Times Cited: 31
Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson’s disease like pathology in Zebrafish
Qingyu Ren, Xin Jiang, Yam Nath Paudel, et al.
Journal of Ethnopharmacology (2022) Vol. 292, pp. 115234-115234
Closed Access | Times Cited: 18
Cognitive dysfunction associated with COVID-19: Prognostic role of circulating biomarkers and microRNAs
Marissa Alvarez, Erick Trent, Bruno de Souza Gonçalves, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
The Janus face of antipsychotics in glial cells: Focus on glioprotection
Izaviany Schmitz, Amanda da Silva, Larissa Daniele Bobermin, et al.
Experimental Biology and Medicine (2023) Vol. 248, Iss. 22, pp. 2120-2130
Open Access | Times Cited: 8
Lead‐Induced Motor Dysfunction Is Associated with Oxidative Stress, Proteome Modulation, and Neurodegeneration in Motor Cortex of Rats
Luana Ketlen Reis Leão, Leonardo Oliveira Bittencourt, Ana Carolina Alves de Oliveira, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 19
Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders
Deepali Goswami, Urati Anuradha, Anok Angati, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 10, pp. 1403-1416
Closed Access | Times Cited: 13
Neutrophil Elastase, Neuron-Specific Enolase, and S100B Protein as Potential Markers of Long-Term Complications Caused by COVID-19 in Patients with Type 2 Diabetes Mellitus (T2DM) and Advanced Stage of Diabetic Nephropathy (NfT2DM)—Observational Studies
Maciej Rabczyński, Sandra Chwałek, Joanna Adamiec-Mroczek, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11791-11791
Open Access | Times Cited: 2
Neuroprotective Effects of Phenolic Antioxidant Tert-butylhydroquinone (tBHQ) in Brain Diseases
Xiaojin Liu, Luodan Yang, Guoying Zhang, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 9, pp. 4909-4923
Closed Access | Times Cited: 6
A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology
Giselle Prunell, Silvia Olivera‐Bravo
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1745-1745
Open Access | Times Cited: 10
Pathophysiology and Neuroimmune Interactions Underlying Parkinson’s Disease and Traumatic Brain Injury
Alyssa Lillian, Wanhong Zuo, Linda Laham, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7186-7186
Open Access | Times Cited: 5
Altered expression of Sialyl Lewis X in experimental models of Parkinson’s disease
Maria João Nunes, Andreia Neves Carvalho, Alexandra I. Rosa, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 3, pp. 365-377
Open Access | Times Cited: 1
Phosphoglycerate kinase (PGK) 1 succinylation modulates epileptic seizures and the blood-brain barrier
Yuemei Luo, Juan Yang, Lijia Zhang, et al.
EXPERIMENTAL ANIMALS (2023) Vol. 72, Iss. 4, pp. 475-489
Open Access | Times Cited: 4
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats
Yorran Hardman Araújo Montenegro, Larissa Daniele Bobermin, Patrícia Sesterheim, et al.
Journal of NeuroVirology (2023) Vol. 29, Iss. 5, pp. 577-587
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top